Latest Advances

  • Condition: Skull Base Tumor
  • Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • Treatment Used: Endoscopic Endonasal Approach Combined with the Frontotemporal Orbitozygomatic Approach Under the Microscope
  • Number of Patients: 7
  • Published —
The aim of this study was to evaluate the application of the endoscopic endonasal approach combined with the frontotemporal orbitozygomatic approach microscopically in skull base tumor with intra and extra-cranial involvement.
  • Condition: Nested Variant of Urothelial Carcinoma of the Bladder
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Radical Cystectomy and Modified Studer Orthotopic Neobladder Reconstruction
  • Number of Patients: 1
  • Published —
This case report describes a patient with a nested variant of urothelial carcinoma of the bladder.
  • Condition: Metachronous Bilateral Epididymal Tuberculosis after Bacillus Calmette-Guerin (BCG) Instillation Therapy
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Surgery and Anti-Tuberculosis Drugs
  • Number of Patients: 1
  • Published —
This case report describes an 83-year-old male diagnosed with metachronus bilateral epidyidymal tuberculosis after bacillus Calmette-Guerin (BCG) instillation.
  • Condition: Non-Muscle-Invasive Bladder Cancer
  • Journal: The Lancet. Oncology
  • Treatment Used: Intravesical Nadofaragene Firadenovec Therapy
  • Number of Patients: 198
  • Published —
The study researched the use of intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer.
  • Condition: Genitourinary Cancer Liver Metastases
  • Journal: Surgical oncology clinics of North America
  • Treatment Used: Surgery
  • Number of Patients: 0
  • Published —
This article discusses the surgical management of genitourinary cancer liver metastases.
  • Condition: High Risk Upper Tract Urothelial Carcinoma with Cardiovascular Comorbidity
  • Journal: Scientific reports
  • Treatment Used: Adjuvant Chemotherapy after Radical Nephroureterectomy
  • Number of Patients: 176
  • Published —
This study tested the safety and efficacy of using adjuvant chemotherapy after radical nephroureterectomy to treat patients with high risk upper tract urothelial carcinoma with cardiovascular comorbidity.
  • Condition: High-Risk Urothelial Carcinoma
  • Journal: Nature medicine
  • Treatment Used: PD-L1 plus CTLA-4 Blockade
  • Number of Patients: 28
  • Published —
The study researched the outcomes of using PD-L1 plus CTLA-4 blockade to treat high-risk urothelial carcinoma.
  • Condition: Metastatic, Platinum-Treated Urothelial Carcinoma
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Avelumab
  • Number of Patients: 249
  • Published —
This study tested the safety and efficacy of using avelumab to treat patients with metastatic, platinum-treated urothelial carcinoma.
  • Condition: Metastatic Urothelial Carcinoma
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Pembrolizumab and Nab-Paclitaxel
  • Number of Patients: 70
  • Published —
The study researched the outcomes of Pembrolizumab and Nab-Paclitaxel for treating metastatic urothelial carcinoma.
  • Condition: Urothelial Carcinoma
  • Journal: The New England journal of medicine
  • Treatment Used: Avelumab Maintenance Therapy
  • Number of Patients: 700
  • Published —
The study researched the outcomes of avelumab maintenance therapy for patients with advanced or metastatic urothelial carcinoma.
  • Condition: Urothelial Carcinoma
  • Journal: BMC cancer
  • Treatment Used: 5?-Reductase Inhibitors
  • Number of Patients: 18530
  • Published —
In this study, researchers evaluated the outcomes of using 5?-reductase inhibitors in the treatment of urothelial carcinoma.
  • Condition: Progressive Sarcomatoid Renal Cell Carcinoma
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Second-Line Nivolumab after Surgery
  • Number of Patients: 1
  • Published —
The study researched the outcomes of second-line nivolumab after surgery for progressive sarcomatoid renal cell carcinoma.
Showing 1-12 of 186